Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Zevalin for Patients With Incomplete Response to Chemo Prior to Autologous Stem Cell Transplant for Multiple Myeloma
ClinicalTrials.gov study NCT01207765. IPD Sharing: NO. Countries: 1. Publications: 6.
CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
ClinicalTrials.gov study NCT00056160. IPD Sharing: Not stated. Countries: 2. Publications: 4.
A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
ClinicalTrials.gov study NCT00424047. IPD Sharing: Not stated. Countries: 15. Publications: 4.
Study of Ibrutinib in Combination With Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03702725. IPD Sharing: NO. Countries: 1. Publications: 19.
Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma
ClinicalTrials.gov study NCT00432458. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma
ClinicalTrials.gov study NCT02215967. IPD Sharing: NO. Countries: 1. Publications: 6.
Carfilzomib, Pegylated Liposomal Doxorubicin Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01246063. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.
ClinicalTrials.gov study NCT03158688. IPD Sharing: YES. Countries: 19. Publications: 9.
MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb
ClinicalTrials.gov study NCT04649359. IPD Sharing: YES. Countries: 10. Publications: 7.
Exploratory Trial to Estimate Proportion of Patients With Tumor Cell Contaminated Leukapheresis Products With and Without Bortezomib With In-vivo Purging - Multiple Myeloma (MM)
ClinicalTrials.gov study NCT02703779. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase 1 Study in Subjects With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02561962. IPD Sharing: YES. Countries: 2. Publications: 1.
Bendamustine Hydrochloride, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT01049945. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302)
ClinicalTrials.gov study NCT02440464. IPD Sharing: YES. Countries: 1. Publications: 1.
Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors
ClinicalTrials.gov study NCT01326702. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma
ClinicalTrials.gov study NCT01083602. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM)
ClinicalTrials.gov study NCT03848845. IPD Sharing: YES. Countries: 4. Publications: 1.
Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00903968. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Mobile App Education Based on Orem's Self-Care Model in Multiple Myeloma Patients
ClinicalTrials.gov study NCT07088783. IPD Sharing: NO. Countries: 1. Publications: 2.
Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed, Previously Untreated Multiple Myeloma
ClinicalTrials.gov study NCT01029054. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma
ClinicalTrials.gov study NCT00084747. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.